Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan
Nobuyuki Horita, Takeshi Kaneko Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan Abstract: Once-daily dual-bronchodilator therapy with combined indacaterol and glycopyrronium bromide in one device (Ultibro, Breezhaler), often called QVA149, was first...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/role-of-combined-indacaterol-and-glycopyrronium-bromide-qva149-for-the-peer-reviewed-article-COPD |